Skip to main content
Jane Winter, MD, Hematology, Chicago, IL

JaneWinterMD

Hematology • Chicago, IL

Hematologic Oncology

Professor in Medicine-Hematology/Oncology, Feinberg School of Medicine, Northwestern University

Join to view full profile

Dr. Winter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Winter's full profile

Already have an account?

  • Office

    675 N Saint Clair St, 21-100 Galter Pavilion
    Chicago, IL 60611
    Phone+1 312-695-0990
    Fax+1 312-695-4770

Summary

  • Dr. Jane Winter, MD is a Hematologist based in Chicago, IL, with a subspecialty in Hematologic Oncology. She has extensive experience in treating non-Hodgkin lymphoma and Hodgkin's lymphoma. Dr. Winter is trained in Hematology and Medical Oncology from McGaw Medical Center of Northwestern University and the New York Presbyterian Hospital. Her residency was undertaken in Internal Medicine at the University of Chicago and she is an alumnus of the Perelman School of Medicine at the University of Pennsylvania. Dr. Winter has contributed significantly to the field with numerous publications in Blood Advances, particularly on lymphomas and CAR-T therapy. She has extensive experience as a principal investigator for multiple clinical trials, working primarily with lymphoma treatments. Her consistent excellence in her field has earned her a host of honors including being recognized multiple times as one of "America's Top Doctors" by Castle Connolly.

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1981 - 1982
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 1980 - 1981
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1977 - 1980
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1977

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1978 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A Phase I/II Trial of Brentuximab Vedotin (BV) Plus Rituximab (R) As Frontline Therapy for Patients with Immunosuppression-Associated CD30+ and/or EBV+ Lymphomas
    Jane N. Winter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Brief Pembrolizumab(PEM) Monotherapy Results in Complete and Near Complete Responses in the Majority of Untreated Patients with Classical Hodgkin Lymphoma (cHL): A Mul...
    Jane N. Winter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classi...
    Jane N. Winter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • A Phase II Studyof Sequential Pembrolizumab (PEM) Followed By AVD for Frontline Treatment of Classical Hodgkin Lymphoma (CHL): Quantifying Response Following PEM Monot... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Steep Price for Surviving Childhood Lymphoma: Epigenetic Aging
    Steep Price for Surviving Childhood Lymphoma: Epigenetic AgingDecember 13th, 2022
  • New Data: The Drug Ibrutinib May Help Some Younger Mantle Cell Lymphoma Patients Avoid a Stem Cell Transplant
    New Data: The Drug Ibrutinib May Help Some Younger Mantle Cell Lymphoma Patients Avoid a Stem Cell TransplantDecember 12th, 2022
  • 'Unparalleled Times' in Hematology, but Workforce Issues Persist
    'Unparalleled Times' in Hematology, but Workforce Issues PersistSeptember 26th, 2022
  • Join now to see all

Professional Memberships

Dr. Jane Winter, Dr. Jane Winter, MD, Dr. J Winter